Catherine Novack
Stock Analyst at Jones Trading
(2.06)
# 2,833
Out of 5,174 analysts
24
Total ratings
25%
Success rate
3.58%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Catherine Novack
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IBIO iBio, Inc. | Initiates: Buy | $7 | $2.08 | +236.54% | 1 | Mar 3, 2026 | |
| SEPN Septerna | Initiates: Buy | $43 | $23.44 | +83.45% | 1 | Dec 23, 2025 | |
| KRRO Korro Bio | Downgrades: Hold | n/a | $10.58 | - | 2 | Nov 14, 2025 | |
| AARD Aardvark Therapeutics | Initiates: Buy | $33 | $3.77 | +775.33% | 1 | Oct 1, 2025 | |
| DYN Dyne Therapeutics | Initiates: Buy | $30 | $17.85 | +68.07% | 1 | Jun 26, 2025 | |
| CAPR Capricor Therapeutics | Maintains: Buy | $40 → $29 | $28.87 | +0.45% | 2 | Jun 25, 2025 | |
| FEMY Femasys | Maintains: Buy | $10 → $6 | $0.51 | +1,069.36% | 2 | May 13, 2025 | |
| RLYB Rallybio | Downgrades: Hold | n/a | $8.65 | - | 1 | Apr 15, 2025 | |
| PVLA Palvella Therapeutics | Initiates: Buy | $45 | $116.23 | -61.28% | 1 | Mar 25, 2025 | |
| PRQR ProQR Therapeutics | Initiates: Buy | $11 | $1.49 | +640.74% | 1 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.95 | - | 1 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $16 | $11.63 | +37.58% | 2 | Sep 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $14 | $4.57 | +206.35% | 1 | Sep 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $13 | $1.36 | +855.88% | 2 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $2.69 | +271.75% | 1 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $0.62 | +3,444.39% | 1 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $6.41 | - | 2 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $1,600 | $3.97 | +40,253.09% | 1 | Jul 21, 2023 |
iBio, Inc.
Mar 3, 2026
Initiates: Buy
Price Target: $7
Current: $2.08
Upside: +236.54%
Septerna
Dec 23, 2025
Initiates: Buy
Price Target: $43
Current: $23.44
Upside: +83.45%
Korro Bio
Nov 14, 2025
Downgrades: Hold
Price Target: n/a
Current: $10.58
Upside: -
Aardvark Therapeutics
Oct 1, 2025
Initiates: Buy
Price Target: $33
Current: $3.77
Upside: +775.33%
Dyne Therapeutics
Jun 26, 2025
Initiates: Buy
Price Target: $30
Current: $17.85
Upside: +68.07%
Capricor Therapeutics
Jun 25, 2025
Maintains: Buy
Price Target: $40 → $29
Current: $28.87
Upside: +0.45%
Femasys
May 13, 2025
Maintains: Buy
Price Target: $10 → $6
Current: $0.51
Upside: +1,069.36%
Rallybio
Apr 15, 2025
Downgrades: Hold
Price Target: n/a
Current: $8.65
Upside: -
Palvella Therapeutics
Mar 25, 2025
Initiates: Buy
Price Target: $45
Current: $116.23
Upside: -61.28%
ProQR Therapeutics
Feb 12, 2025
Initiates: Buy
Price Target: $11
Current: $1.49
Upside: +640.74%
Nov 1, 2024
Downgrades: Hold
Price Target: n/a
Current: $1.95
Upside: -
Sep 25, 2024
Maintains: Buy
Price Target: $12 → $16
Current: $11.63
Upside: +37.58%
Sep 12, 2024
Initiates: Buy
Price Target: $14
Current: $4.57
Upside: +206.35%
Aug 16, 2024
Maintains: Buy
Price Target: $5 → $13
Current: $1.36
Upside: +855.88%
Apr 18, 2024
Initiates: Buy
Price Target: $10
Current: $2.69
Upside: +271.75%
Feb 16, 2024
Initiates: Buy
Price Target: $22
Current: $0.62
Upside: +3,444.39%
Oct 5, 2023
Downgrades: Hold
Price Target: n/a
Current: $6.41
Upside: -
Jul 21, 2023
Initiates: Buy
Price Target: $1,600
Current: $3.97
Upside: +40,253.09%